Literature DB >> 24220296

Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage.

C Gray1, M S Ahmed1, A Mubarak1, A V Kasbekar2, S Derbyshire2, M S McCormick3, M K Mughal4, P S McNamara5, T Mitchell6, Q Zhang1.   

Abstract

Pneumococcal carriage is common in children that may account for the high incidence of disease in this age group. Recent studies in animals suggest an important role for CD4+ T cells, T helper type 17 (Th17) cells in particular, in pneumococcal clearance. Whether this Th17-mediated mechanism operates in humans and what pneumococcal components activate Th17 are unknown. We investigated the ability of domain 4 pneumolysin (D4Ply) to activate CD4+ T cells including Th17 in human nasopharynx-associated lymphoid tissue (NALT) and peripheral blood. We show that D4Ply elicited a prominent CD4+ T-cell proliferative response. More importantly, D4Ply elicited a significant memory Th17 response in NALT, and a moderate response in peripheral blood mononuclear cells (PBMCs). This D4Ply-elicited memory Th17 response was more marked in carriage- than in carriage+ children in both NALT and PBMCs. In contrast, no difference was shown in D4Ply-induced Th1 response between the two groups. We also show D4Ply activated human monocytes and murine macrophages that was in part dependent on Toll-like receptor 4 (TLR-4). Our results support a protective role of Th17 against pneumococcal carriage in human nasopharynx, and identify a novel property of D4Ply to activate Th17 in NALT that may offer an attractive vaccine candidate in intranasal immunization against pneumococcal infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24220296     DOI: 10.1038/mi.2013.89

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  51 in total

Review 1.  Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Authors:  Richard Malley; Porter W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

2.  Adenoidectomy and nasopharyngeal carriage of Streptococcus pneumoniae in young children.

Authors:  Petri S Mattila; Sari Hammarén-Malmi; Harri Saxen; Tarja Kaijalainen; Helena Käyhty; Jussi Tarkkanen
Journal:  Arch Dis Child       Date:  2010-05-26       Impact factor: 3.791

3.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Novel pneumococcal surface proteins: role in virulence and vaccine potential.

Authors:  J C Paton
Journal:  Trends Microbiol       Date:  1998-03       Impact factor: 17.079

Review 5.  Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.

Authors:  Katherine L O'Brien; Hanna Nohynek
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

6.  Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.

Authors:  Qibo Zhang; Linda Bagrade; Jolanta Bernatoniene; Ed Clarke; James C Paton; Tim J Mitchell; Desmond A Nunez; Adam Finn
Journal:  J Infect Dis       Date:  2007-03-06       Impact factor: 5.226

7.  Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae.

Authors:  Marie Olliver; Jeffni Hiew; Peter Mellroth; Birgitta Henriques-Normark; Peter Bergman
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

8.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

9.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

10.  Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.

Authors:  Kristin L Moffitt; Richard Malley; Ying-Jie Lu
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more
  18 in total

Review 1.  The host immune dynamics of pneumococcal colonization: implications for novel vaccine development.

Authors:  M Nadeem Khan; Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Screening for Th17-Dependent Pneumococcal Vaccine Antigens: Comparison of Murine and Human Cellular Immune Responses.

Authors:  Adam Finn; Richard Malley; Ying-Jie Lu; Elizabeth Oliver; Fan Zhang; Caroline Pope
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

3.  Reduced T-Helper 17 Responses to Streptococcus pneumoniae in Infection-Prone Children Can Be Rescued by Addition of Innate Cytokines.

Authors:  Saleem Basha; Ravinder Kaur; Tim R Mosmann; Michael E Pichichero
Journal:  J Infect Dis       Date:  2017-04-15       Impact factor: 5.226

4.  An ahemolytic pneumolysin of Streptococcus pneumoniae manipulates human innate and CD4⁺ T-cell responses and reduces resistance to colonization in mice in a serotype-independent manner.

Authors:  M Nadeem Khan; John Robert Coleman; Joshua Vernatter; Avanish Kumar Varshney; Chad Dufaud; Liise-Anne Pirofski
Journal:  J Infect Dis       Date:  2014-06-13       Impact factor: 5.226

Review 5.  Next generation protein based Streptococcus pneumoniae vaccines.

Authors:  Michael E Pichichero; M Nadeem Khan; Qingfu Xu
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

6.  Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial.

Authors:  Stephanie Ascough; Iris Vlachantoni; Mohini Kalyan; Bert-Jan Haijema; Sanna Wallin-Weber; Margriet Dijkstra-Tiekstra; Muhammad S Ahmed; Maarten van Roosmalen; Roberto Grimaldi; Qibo Zhang; Kees Leenhouts; Peter J Openshaw; Christopher Chiu
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

7.  Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis.

Authors:  Santanu Banerjee; Jana Ninkovic; Jingjing Meng; Umakant Sharma; Jing Ma; Richard Charboneau; Sabita Roy
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

8.  Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea.

Authors:  J P Francis; P C Richmond; D Strickland; S L Prescott; W S Pomat; A Michael; M A Nadal-Sims; C J Edwards-Devitt; P G Holt; D Lehmann; A H J van den Biggelaar
Journal:  Clin Exp Immunol       Date:  2016-12-18       Impact factor: 4.330

9.  Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1.

Authors:  Els van Westen; Martien C M Poelen; Germie P J M van den Dobbelsteen; Eliud O Oloo; Martina M Ochs; Nynke Y Rots; Cecile A C M van Els
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

Review 10.  The immunological mechanisms that control pneumococcal carriage.

Authors:  Simon P Jochems; Jeffrey N Weiser; Richard Malley; Daniela M Ferreira
Journal:  PLoS Pathog       Date:  2017-12-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.